Search

Author/Creator Roboz, G. J.

1. P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG-TERM SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION AFTER CHEMOTHERAPY IN THE QUAZAR AML-001 TRIAL OF ORAL AZACITIDINE. (23rd June 2022)

Authors:
Wei, A. H.; Döhner, H.; Sayar, H.; Ravandi, F.; Montesinos, P.; Dombret, H.; Selleslag, D.; Porkka, K.; Jang, J.-H.; Skikne, B.; Beach, C.; Prebet, T.; Zhang, G.; Risueño, A.; Ugidos Guerrero, M.; See, W. L.; Menezes, D.; Roboz, G. J.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
397
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P765: UPDATED ENROLLMENT AND RESULTS FROM THE PHASE 1 SUBSTUDY OF IVOSIDENIB IN PATIENTS WITH IDH1-MUTANT RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROME (R/R MDS). (23rd June 2022)

Authors:
DiNardo, C. D.; Foran, J. M.; Watts, J. M.; Stein, E. M.; de Botton, S.; Fathi, A. T.; Prince, G. T.; Stone, R. M.; Patel, P. A.; Roboz, G. J.; Arellano, M. L.; Erba, H. P.; Pigneux, A.; Baratam, P.; Stuart, R. K.; Thomas, X.; Lemieux, I. R.; Bai, X.; Kapsalis, S. M.; Garcia-Manero, G.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
660
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search